{"name":"StemCyte, Inc.","slug":"stemcyte-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"REGENECYTE","genericName":"REGENECYTE","slug":"regenecyte","indication":"Chronic heart failure","status":"phase_3"}]}],"pipeline":[{"name":"REGENECYTE","genericName":"REGENECYTE","slug":"regenecyte","phase":"phase_3","mechanism":"REGENECYTE is a cell therapy that uses expanded autologous bone marrow-derived stem cells to promote tissue regeneration and repair.","indications":["Chronic heart failure","Myocardial infarction"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxPSkx5VHgxbGpTY0g1YXoyUDYwMDllbWxkd1pWZGZBYjJHbVhONUpXWHZMdDhrZ1RFRmxvZVAyVkRNUUUtZFFweGNUQXllby1IdnhkUkpZSUNRcmJIdlNaaEU1eGZHVFBjMmw2MlRlQ0t4NmpsWC1xQ18tUXNiU2RXMzN0amsyaG9UR1J1TnZJZTA3M3pjbjhuaG9KRVYwUWNyMlVnRjdRVFVwQkFUUUNNTEhhcE9VcXdvUHBud0plWERQZTAwOEJ4VjFEdFk4OEVud2tXY2tmRHA3TUJNVlc4cy1TXzVBQ3ZfbkpXc1FiTTlfME5SREJSemw0cGpwTExQTFhoWlFXYmpjcnRHOVk3ckR3czJvTEp5MU9aeFFkTk1ueE9vQ0k1NTd4MUJFNWRKVmdHM0tIek1PTk9mdV8xZ21ibDNHUTBYd0dpdGRTQUZvbUk?oc=5","date":"2026-03-30","type":"regulatory","source":"Barchart.com","summary":"Spinal Cord Injury Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment By DelveInsight | StemCyte, NervGen Pharma, VA Office of Research and Development, Kessler - ","headline":"Spinal Cord Injury Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment By DelveInsig","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNV1o2dmhpX09fSFA1TmZqaGRSdVJKMi1CQXl1NHpEb1UwalY5R3BsZDZKcERZSUJ5UllvWUplSl8yVl9aWFhXenR6MksxejN0anZmTlctRGlZZWkxbGswMlhpd0FhbkZ5bFFiLVgtdjhBVmR2NTUyS19uWmp0QnFvZEhJa3pVNm1kNVR4RDhUcjhBRE9Ebjk1VkFIV21Rc0U5V214azNhbkRxWE80bU1FNkI3WVN2VWNxY3NESy02dGhfZ0RZdy1famJqWQ?oc=5","date":"2026-01-29","type":"regulatory","source":"Pharmacy Times","summary":"Positive Phase 2a Trial Data Support FDA Clearance of StemCyte’s HPC Therapy for Long COVID - Pharmacy Times","headline":"Positive Phase 2a Trial Data Support FDA Clearance of StemCyte’s HPC Therapy for Long COVID","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxPYjhjTUE5UlRGMjZhTWRSR01PUVpuNGh3dUJfVkgwU3VEdXV5SkgyeklIUFVzVW9ENXpvbGRsRjJsNG4xY1QxYmlZbms0cDI4SGlsLWhsRV9fNDRZQ1RtUTZ6WUl4OFhDRklUT1daSUNIUHBndHpYSUt2SU05NVpvOWRPUDZESkhRMlFsNHRrRzg3U3VPVmppRU9PRnJ6eWJYVVQ5Mk5ncy1JVDBiTERORUM1ME05QkRaNU5LRDVQc0ZxNGd0U0g5V3ppQnZQS2ZVT3d4ckoxaXk2aW8tdTI5T0xRcWV5djQ3UzBnd0NrSGlpcnhaeG9ncndNNWJYMTVBMDJRQkVJZ2U3b2E3ZFE?oc=5","date":"2026-01-26","type":"regulatory","source":"PR Newswire","summary":"StemCyte Announces FDA Clearance of Expanded Access Program for RegeneCyte® (HPC, Cord Blood) to Address Unmet Need in Long COVID - PR Newswire","headline":"StemCyte Announces FDA Clearance of Expanded Access Program for RegeneCyte® (HPC, Cord Blood) to Address Unmet Need in L","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPUjI1MnltanVCc2E4UEpGOWd0Sk5lQjRkeTB2X1FXbXBVUnZLSGlUa3VOaDVxeS15RG5HU3d5X2VoRllFRm0yS2ZaWE1GaWFROFVUanYyQ2tOb2x0akZ0dzZsRWxsdG1GX3lGekhrVWJrRmNVb1otZmV0Nm1aMDYtWXFDNWFfS3ZxdUp0cXZDcDhON2g2c0ZFbTFYRjJ2dVE5VnJUQXBocUlvaG9YNjhMSHNtcW9jXzNFck5qaHpGV1lwTkgyQkhKTnlDaFo3cjhWXzNvLXJ0LWZwMmtJazloTk0ybDE3Yzh6b1dfckNn?oc=5","date":"2024-11-22","type":"regulatory","source":"PR Newswire","summary":"U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE™ Cord Blood Cell Therapy Product - PR Newswire","headline":"U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE™ Cord Blood Cell Therapy Product","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPOWVRMjN3Tkg2VFgzMkY1OUtHejZIOEh3OFR2RFRqSGVHYUVpRklLZFRJR3ZqX00tekhyenRIOTJVVDY2NzZBWFRUS2ZlaTh5UzF1NWYwNWVuUFZxUEhaTzl2S3V5Nzc2TDB4bXhWcVNNUHZDSkl1a3VrTzBidFZhVDJETjdJeU5uU1dTeHpYSUlMWDZNeTg3ZGsteHFaVFV1eDhGa1RfTHNpRHFCakV3ckhEdE1UUko0dEpIZ05KSQ?oc=5","date":"2021-08-04","type":"pipeline","source":"PR Newswire","summary":"StemCyte Announces Breakthrough Allogeneic Cell Therapy Technology - PR Newswire","headline":"StemCyte Announces Breakthrough Allogeneic Cell Therapy Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQQ2Fmck53Vmo5N0VzM3d3Ry1UUXppemdQUHJLQXo2LXdfOV9MZG0tcmNWeHd5UnVxUjdhLUZsanhpN2cxVjloZGY0cWZKR056cHduSWZRTndVTzY2MEpudGplY1hrUnYtaG5VOW5rR3BaSDUyY3R6MnE3Uml0WGlHWlZwZXd2eDBaSFBjRW1ybnZmMW1CNFc1M1U0bXYyaWpTTE9yZ3ZpRlNXYzdPeENPR0g3VlI4ejJqbHFkRWk1a01sSXNFZFNla1VISmxPNjAzcHB6YVpYTWNob1Vpd2hpOG1n?oc=5","date":"2016-12-23","type":"pipeline","source":"PR Newswire","summary":"StemCyte India - 1st Cord Blood Bank in India to Receive International FACT Accreditation - PR Newswire","headline":"StemCyte India - 1st Cord Blood Bank in India to Receive International FACT Accreditation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOTUZxU252QWlaUE5pUmdWS0JveEthRlJMX2VXeUs0TFJLOWt0T3U3YWJNSmdGbDY0cGlxa0hHQmZYYzBiclJtbHBlVjI3eDljLTBqVlByclkwV0tWcFNacjJMb3ctOXhJcHZva181SEQ5dHJpWVZXY2dsR2VqUWlOdVVqXzhGcWNPdm5OY09nY0dJRGkxNWE0ZThfbXg4azJsT0s3eTcxckJrWEliMlg1R3pR?oc=5","date":"2014-11-12","type":"pipeline","source":"DeshGujarat","summary":"Cadila Pharma to hold life sciences-focused innovation conclave IAMICON 2014 - DeshGujarat","headline":"Cadila Pharma to hold life sciences-focused innovation conclave IAMICON 2014","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2014-01-28","type":"pipeline","source":"Business Standard","summary":"Carrying the legacy forward: Rajiv Modi - Business Standard","headline":"Carrying the legacy forward: Rajiv Modi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPR2hQMUw1WmM1WUdBaC1URXRmOXFFZXJHeC14eW1QU2dkVlA2VGpNbVBzbUx3aUdLdV9xWEF3cElhcVo4WTJ5NF9IZkYwM1FqWW5oS082OGs0NGEyZUc3Q0NuVlV1Z182SHUxcXhVeVFwWW0xNlRvcUsxa3RvRXRVRDdLSDlQWXpyRlZFRDc3OVRoRE5IR2RaLUVSSmVSWmhOemNycy1GNWowamRPOVlzNkx1VzYxNHE2WUlKM2R5c0RWSi1zUnJrb2R3OGZlLUc3V1JyaFJSa0RQa2I5d1JOVUp1QXlzNkE?oc=5","date":"2010-02-25","type":"pipeline","source":"The Economic Times","summary":"StemCyte opens it first UCB stem cell bank of India at Apollo - The Economic Times","headline":"StemCyte opens it first UCB stem cell bank of India at Apollo","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}